Latest News and Press Releases
Want to stay updated on the latest news?
-
GAITHERSBURG, Md., Jan. 15, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
-
Pivotal Phase 3 trial in United Kingdom completes enrollmentPhase 2b efficacy trial in South Africa completes enrollment U.S./Mexico Phase 3 trial expected to begin in the coming weeks ...